- $192.28m
- $125.69m
- $129.42m
Brief: Niagen Bioscience Announces $10 Million Share Repurchase Program
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance
Brief: Niagen Bioscience Inc Q3 Net Income USD 4.578 Million
Brief: Niagen Bioscience Increases Full Year 2025 Net Sales Outlook To 25% To 30% Year-Over-Year Growth
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 sales beat estimates
Niagen Bioscience Inc expected to post earnings of 1 cent a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting Potential Of Nicotinamide Riboside (NR) For Werner Syndrome, A Rare Genetic Disorder
Niagen Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
Brief: Niagen Bioscience Welcomes Pinchas Cohen To Scientific Advisory Board
Brief: Niagen Bioscience Confirms Its Operations Remain Unaffected By New Tariffs
Brief: Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments
Brief: Chromadex announces name change and new ticker symbol effective March 19
Chromadex Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results
Chromadex Corp expected to post earnings of 2 cents a share - Earnings Preview
ChromaDex surges on surprise Q3 profit